1948 related articles for article (PubMed ID: 26289314)
1. Glycosylation in cancer: mechanisms and clinical implications.
Pinho SS; Reis CA
Nat Rev Cancer; 2015 Sep; 15(9):540-55. PubMed ID: 26289314
[TBL] [Abstract][Full Text] [Related]
2. Glycosylation in cancer: Selected roles in tumour progression, immune modulation and metastasis.
Rodrigues JG; Balmaña M; Macedo JA; Poças J; Fernandes Â; de-Freitas-Junior JCM; Pinho SS; Gomes J; Magalhães A; Gomes C; Mereiter S; Reis CA
Cell Immunol; 2018 Nov; 333():46-57. PubMed ID: 29576316
[TBL] [Abstract][Full Text] [Related]
3. Glycans as Regulatory Elements of the Insulin/IGF System: Impact in Cancer Progression.
de-Freitas-Junior JCM; Andrade-da-Costa J; Silva MC; Pinho SS
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28880250
[TBL] [Abstract][Full Text] [Related]
4. Exploring glycans as vital biological macromolecules: A comprehensive review of advancements in biomedical frontiers.
Arora K; Sherilraj PM; Abutwaibe KA; Dhruw B; Mudavath SL
Int J Biol Macromol; 2024 May; 268(Pt 1):131511. PubMed ID: 38615867
[TBL] [Abstract][Full Text] [Related]
5. Glycosylation in health and disease.
Reily C; Stewart TJ; Renfrow MB; Novak J
Nat Rev Nephrol; 2019 Jun; 15(6):346-366. PubMed ID: 30858582
[TBL] [Abstract][Full Text] [Related]
6. Cell surface glycan-lectin interactions in tumor metastasis.
Rambaruth ND; Dwek MV
Acta Histochem; 2011 Oct; 113(6):591-600. PubMed ID: 21501858
[TBL] [Abstract][Full Text] [Related]
7. Importance of altered glycoprotein-bound N- and O-glycans for epithelial-to-mesenchymal transition and adhesion of cancer cells.
Lange T; Samatov TR; Tonevitsky AG; Schumacher U
Carbohydr Res; 2014 May; 389():39-45. PubMed ID: 24491280
[TBL] [Abstract][Full Text] [Related]
8. Cadherins Glycans in Cancer: Sweet Players in a Bitter Process.
Carvalho S; Reis CA; Pinho SS
Trends Cancer; 2016 Sep; 2(9):519-531. PubMed ID: 28741480
[TBL] [Abstract][Full Text] [Related]
9. Hallmarks of glycosylation in cancer.
Munkley J; Elliott DJ
Oncotarget; 2016 Jun; 7(23):35478-89. PubMed ID: 27007155
[TBL] [Abstract][Full Text] [Related]
10. Alterations in glycosylation as biomarkers for cancer detection.
Reis CA; Osorio H; Silva L; Gomes C; David L
J Clin Pathol; 2010 Apr; 63(4):322-9. PubMed ID: 20354203
[TBL] [Abstract][Full Text] [Related]
11. Enzymes for N-Glycan Branching and Their Genetic and Nongenetic Regulation in Cancer.
Kizuka Y; Taniguchi N
Biomolecules; 2016 Apr; 6(2):. PubMed ID: 27136596
[TBL] [Abstract][Full Text] [Related]
12. Altered glycosylation in cancer: A promising target for biomarkers and therapeutics.
Thomas D; Rathinavel AK; Radhakrishnan P
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188464. PubMed ID: 33157161
[TBL] [Abstract][Full Text] [Related]
13. Glycans and cancer: role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics.
Taniguchi N; Kizuka Y
Adv Cancer Res; 2015; 126():11-51. PubMed ID: 25727145
[TBL] [Abstract][Full Text] [Related]
14. [Human lectins and their correspondent glycans in cell biology and clinical medicine].
Köttgen E; Reutter W; Tauber R
Med Klin (Munich); 2003 Dec; 98(12):717-38. PubMed ID: 14685673
[TBL] [Abstract][Full Text] [Related]
15. The cancer glycome: carbohydrates as mediators of metastasis.
Glavey SV; Huynh D; Reagan MR; Manier S; Moschetta M; Kawano Y; Roccaro AM; Ghobrial IM; Joshi L; O'Dwyer ME
Blood Rev; 2015 Jul; 29(4):269-79. PubMed ID: 25636501
[TBL] [Abstract][Full Text] [Related]
16. Cancer glycomics offers potential biomarkers and therapeutic targets in the framework of 3P medicine.
Guo Y; Jia W; Yang J; Zhan X
Front Endocrinol (Lausanne); 2022; 13():970489. PubMed ID: 36072925
[TBL] [Abstract][Full Text] [Related]
17. The intestinal glycome and its modulation by diet and nutrition.
Kavanaugh D; O'Callaghan J; Kilcoyne M; Kane M; Joshi L; Hickey RM
Nutr Rev; 2015 Jun; 73(6):359-75. PubMed ID: 26011911
[TBL] [Abstract][Full Text] [Related]
18. On the trail of the glycan codes stored in cancer-related cell adhesion proteins.
Hoja-Łukowicz D; Przybyło M; Duda M; Pocheć E; Bubka M
Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3237-3257. PubMed ID: 27565356
[TBL] [Abstract][Full Text] [Related]
19. Glycosylation: a hallmark of cancer?
Vajaria BN; Patel PS
Glycoconj J; 2017 Apr; 34(2):147-156. PubMed ID: 27975160
[TBL] [Abstract][Full Text] [Related]
20. Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targets.
Chugh S; Gnanapragassam VS; Jain M; Rachagani S; Ponnusamy MP; Batra SK
Biochim Biophys Acta; 2015 Dec; 1856(2):211-25. PubMed ID: 26318196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
